Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. [electronic resource]
Producer: 20070227Description: 20-8 p. digitalISSN:- 1522-8517
- Animals
- Antineoplastic Agents -- administration & dosage
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Doxorubicin -- administration & dosage
- Drug Delivery Systems
- Glioblastoma -- drug therapy
- Humans
- Male
- Polyethylene Glycols -- administration & dosage
- Rats
- Rats, Nude
- Rats, Sprague-Dawley
- Survival Rate
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- Topotecan -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.